Characterization of amino acid substitutions in feline coronavirus 3C-like protease from a cat with feline infectious peritonitis treated with a protease inhibitor

Krishani Dinali Perera, Athri Rathnayake, Hongwei Liu, Niels C Pedersen, William C. Groutas, Kyeong Ok Chang, Yunjeong Kim

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Feline infectious peritonitis (FIP) is a highly fatal disease caused by a virulent feline coronavirus in domestic and wild cats. We have previously reported the synthesis of potent coronavirus 3C-like protease (3CLpro) inhibitors and the efficacy of a protease inhibitor, GC376, in client-owned cats with FIP. In this study, we studied the effect of the amino acid changes in 3CLpro of feline coronavirus from a feline patient who received antiviral treatment for prolonged duration. We generated recombinant 3CLpro containing the identified amino acid changes (N25S, A252S or K260 N) and determined their susceptibility to protease inhibitors in the fluorescence resonance energy transfer assay. The assay showed that N25S in 3CLpro confers a small change (up to 1.68-fold increase in the 50% inhibitory concentration) in susceptibility to GC376, but other amino acid changes do not affect susceptibility. Modelling of 3CLpro carrying the amino acid changes was conducted to probe the structural basis for these findings. The results of this study may explain the observed absence of clinical resistance to the long-term antiviral treatment in the patients.

Original languageEnglish (US)
Article number108398
JournalVeterinary Microbiology
Volume237
DOIs
StatePublished - Oct 1 2019

Fingerprint

Feline Infectious Peritonitis
Feline Coronavirus
Feline coronavirus
feline infectious peritonitis
amino acid substitution
Amino Acid Substitution
proteinase inhibitors
Protease Inhibitors
Cats
proteinases
cats
amino acids
Amino Acids
Antiviral Agents
Coronavirinae
assays
energy transfer
Fluorescence Resonance Energy Transfer
Coronavirus
Felidae

Keywords

  • 3C-like protease
  • Antivirals
  • Feline coronavirus
  • Feline infectious peritonitis virus
  • Genetic barrier
  • Resistance

ASJC Scopus subject areas

  • Microbiology
  • veterinary(all)

Cite this

Characterization of amino acid substitutions in feline coronavirus 3C-like protease from a cat with feline infectious peritonitis treated with a protease inhibitor. / Perera, Krishani Dinali; Rathnayake, Athri; Liu, Hongwei; Pedersen, Niels C; Groutas, William C.; Chang, Kyeong Ok; Kim, Yunjeong.

In: Veterinary Microbiology, Vol. 237, 108398, 01.10.2019.

Research output: Contribution to journalArticle

Perera, Krishani Dinali ; Rathnayake, Athri ; Liu, Hongwei ; Pedersen, Niels C ; Groutas, William C. ; Chang, Kyeong Ok ; Kim, Yunjeong. / Characterization of amino acid substitutions in feline coronavirus 3C-like protease from a cat with feline infectious peritonitis treated with a protease inhibitor. In: Veterinary Microbiology. 2019 ; Vol. 237.
@article{b69c3928304f4d98951b4d000009f59b,
title = "Characterization of amino acid substitutions in feline coronavirus 3C-like protease from a cat with feline infectious peritonitis treated with a protease inhibitor",
abstract = "Feline infectious peritonitis (FIP) is a highly fatal disease caused by a virulent feline coronavirus in domestic and wild cats. We have previously reported the synthesis of potent coronavirus 3C-like protease (3CLpro) inhibitors and the efficacy of a protease inhibitor, GC376, in client-owned cats with FIP. In this study, we studied the effect of the amino acid changes in 3CLpro of feline coronavirus from a feline patient who received antiviral treatment for prolonged duration. We generated recombinant 3CLpro containing the identified amino acid changes (N25S, A252S or K260 N) and determined their susceptibility to protease inhibitors in the fluorescence resonance energy transfer assay. The assay showed that N25S in 3CLpro confers a small change (up to 1.68-fold increase in the 50{\%} inhibitory concentration) in susceptibility to GC376, but other amino acid changes do not affect susceptibility. Modelling of 3CLpro carrying the amino acid changes was conducted to probe the structural basis for these findings. The results of this study may explain the observed absence of clinical resistance to the long-term antiviral treatment in the patients.",
keywords = "3C-like protease, Antivirals, Feline coronavirus, Feline infectious peritonitis virus, Genetic barrier, Resistance",
author = "Perera, {Krishani Dinali} and Athri Rathnayake and Hongwei Liu and Pedersen, {Niels C} and Groutas, {William C.} and Chang, {Kyeong Ok} and Yunjeong Kim",
year = "2019",
month = "10",
day = "1",
doi = "10.1016/j.vetmic.2019.108398",
language = "English (US)",
volume = "237",
journal = "Veterinary Microbiology",
issn = "0378-1135",
publisher = "Elsevier",

}

TY - JOUR

T1 - Characterization of amino acid substitutions in feline coronavirus 3C-like protease from a cat with feline infectious peritonitis treated with a protease inhibitor

AU - Perera, Krishani Dinali

AU - Rathnayake, Athri

AU - Liu, Hongwei

AU - Pedersen, Niels C

AU - Groutas, William C.

AU - Chang, Kyeong Ok

AU - Kim, Yunjeong

PY - 2019/10/1

Y1 - 2019/10/1

N2 - Feline infectious peritonitis (FIP) is a highly fatal disease caused by a virulent feline coronavirus in domestic and wild cats. We have previously reported the synthesis of potent coronavirus 3C-like protease (3CLpro) inhibitors and the efficacy of a protease inhibitor, GC376, in client-owned cats with FIP. In this study, we studied the effect of the amino acid changes in 3CLpro of feline coronavirus from a feline patient who received antiviral treatment for prolonged duration. We generated recombinant 3CLpro containing the identified amino acid changes (N25S, A252S or K260 N) and determined their susceptibility to protease inhibitors in the fluorescence resonance energy transfer assay. The assay showed that N25S in 3CLpro confers a small change (up to 1.68-fold increase in the 50% inhibitory concentration) in susceptibility to GC376, but other amino acid changes do not affect susceptibility. Modelling of 3CLpro carrying the amino acid changes was conducted to probe the structural basis for these findings. The results of this study may explain the observed absence of clinical resistance to the long-term antiviral treatment in the patients.

AB - Feline infectious peritonitis (FIP) is a highly fatal disease caused by a virulent feline coronavirus in domestic and wild cats. We have previously reported the synthesis of potent coronavirus 3C-like protease (3CLpro) inhibitors and the efficacy of a protease inhibitor, GC376, in client-owned cats with FIP. In this study, we studied the effect of the amino acid changes in 3CLpro of feline coronavirus from a feline patient who received antiviral treatment for prolonged duration. We generated recombinant 3CLpro containing the identified amino acid changes (N25S, A252S or K260 N) and determined their susceptibility to protease inhibitors in the fluorescence resonance energy transfer assay. The assay showed that N25S in 3CLpro confers a small change (up to 1.68-fold increase in the 50% inhibitory concentration) in susceptibility to GC376, but other amino acid changes do not affect susceptibility. Modelling of 3CLpro carrying the amino acid changes was conducted to probe the structural basis for these findings. The results of this study may explain the observed absence of clinical resistance to the long-term antiviral treatment in the patients.

KW - 3C-like protease

KW - Antivirals

KW - Feline coronavirus

KW - Feline infectious peritonitis virus

KW - Genetic barrier

KW - Resistance

UR - http://www.scopus.com/inward/record.url?scp=85071399407&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85071399407&partnerID=8YFLogxK

U2 - 10.1016/j.vetmic.2019.108398

DO - 10.1016/j.vetmic.2019.108398

M3 - Article

C2 - 31585653

AN - SCOPUS:85071399407

VL - 237

JO - Veterinary Microbiology

JF - Veterinary Microbiology

SN - 0378-1135

M1 - 108398

ER -